PCN19: COLORECTAL CANCER SCREENING TESTS: VARIATION IN PREFERENCES BASED ON GENDER AND RACE  by Straus, W et al.
Abstracts 91
PCN18
COLORECTAL CANCER SCREENING: 
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BACKGROUND: Screening can reduce colorectal cancer
mortality, yet screening rates remain low. Data from the
Centers for Disease Control and Prevention (CDC) for
1999 suggest that only 33.7% of US adults over 40 have
ever received a sigmoidoscopy (SIG) or colonoscopy
(COL), and 31.1% have ever received a fecal occult
blood test (FOBT). OBJECTIVE: To inform policy that
may improve screening rates, we sought to characterize
the barriers associated with low screening compliance.
METHODS: A national random sample of US adults 50
years and older was conducted via random digit dial
methods. A computer assisted telephone survey was ad-
ministered to 502 subjects. Data including utilization of
FOBT, SIG, COL and x-ray with barium enema (XBE),
as well as demographics, awareness, concerns, attitudes
and beliefs about those tests were collected. RESULTS:
Screening rates were low, with awareness and screening
rates lower for Blacks/Hispanics than for Whites. For ex-
ample, Blacks and Hispanics were less aware of screening
tests (aware of FOBT  73.3%; SIG  51.7%; COL 
70%; XBE  68.3%) than Whites (88.1%, 81.8%,
87.6% and 80.1%, respectively) (p  .05). Significantly
lower screening compliance is apparent with FOBT
screening rates of 21.7% (Blacks/Hispanics) compared
with 34.8% (Whites). Other significant barriers to
screening found were: discomfort with exam; low health
care seeking behavior; low belief in value of prevention;
and low perceived personal health threat (all p  .05).
CONCLUSIONS: Lack of awareness about screening
still exists, especially among Blacks and Hispanics. Barri-
ers to screening have been observed and can potentially
be addressed by outreach and education programs.
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Knowledge
of Test Ever Had Test
Compliant with
Standards
FOBT 86.7% 70.3% 33.5%
SIG 78.1% 52.0% 29.7%
COL 85.1% 40.7% 31.1%
XBE 78.1% 38.5% 17.5%
BACKGROUND: There exists a larger number of screen-
ing procedures for colorectal cancer than for any other
type of cancer. Unfortunately, screening rates remain
low. Data from the Centers for Disease Control and Pre-
vention (CDC) for 1999 suggest that only 33.7% of US
adults over 40 have ever received a sigmoidoscopy (SIG)
or colonoscopy (COL), and only 31.1% have ever re-
ceived a fecal occult blood test (FOBT). OBJECTIVE: To
better understand the types of barriers associated with
each screening method (stool-based, scope-based, x-ray/
enema-based) in order to develop patient-based prefer-
ence profiles that could be used to increase compliance
with one of the recommended screening regimens. METH-
ODS: A national random sample of US adults 50 years
and older was conducted via random digit dial methods.
A computer assisted telephone survey was administered
to 502 subjects. Data including utilization of FOBT, SIG,
COL and x-ray with barium enema (XBE), demographics,
concerns, attitudes and beliefs were collected. RESULTS:
There were significant gender differences in screening
rates based on procedure. Overall, 26.2% of women were
in compliance with SIG recommendations compared to
38.6% of men (p  .01). White respondents appeared to
be the source of this difference. Black/Hispanic men and
women had similar SIG screening rates. Conversely, there
was a significant difference in stool-based screening com-
pliance between Black/Hispanic men (40.0%) and women
(15.6%) with no gender difference among Whites. The
importance of some potential barriers differed signifi-
cantly with exam type (p  .05), with respondents being
less bothered by, and associating less discomfort with,
the FOBT. CONCLUSIONS: Preferences and perceptions
with respect to screening procedures varied by patient
characteristics. The impact of screening barriers varied by
procedure. Understanding these variations may help in
education and information dissemination and may also
assist in directing patients to more compatible screening
regimens. This might increase screening rates for this
largely preventable disease.
PCN20
COST MINIMIZATION ANALYSIS OF CEFEPIME 
VERSUS IMIPENEM-CILASTATINE IN CANCER 
PATIENTS WITH SHORT-DURATION
FEBRILE NEUTROPENIA
Vorobjov P, Fisenko V, Gerasimov V, Avxentieva M, Moscow 
Medical Academy, Moscow, Russia
OBJECTIVE: To perform pharmacoeconomical compar-
ison of cefepime versus imipenem-cilastatine used for em-
piric therapy in cancer patients with short-duration fe-
brile neutropenia in Russia. METHODS: The decision
tree was designed to analyse the costs and outcomes of
studied treatment. Probabilities of clinical success, ad-
verse events, switching to a new drug and adding extra
antibiotics were extracted from a published multicentral
randomised clinical trial. Firstly the study was planned to
be a cost-effectiveness analysis, but data obtained from
the trial, demonstrated equal efficacy of both drugs. So fi-
